# FDA 483 - New York Cryo - April 25, 2022

Source: https://www.keypedia.com/records/483/new-york-cryo/db7c52b2-e75a-435f-a65a-e8b2d1596f4b

> FDA 483 for New York Cryo on April 25, 2022. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: New York Cryo
- Inspection Date: 2022-04-25
- Product Type: biologics
- Office Name: Division of Human and Animal Food Operations - East I
- Summary: New York Cryo, a reproductive human tissue establishment in Great Neck, NY, was cited for significant deficiencies in its HCT/P donor eligibility determination processes. Observations included approving donors with communicable disease risk factors, failing to complete required testing or review test results before eligibility, and lacking adequate standard operating procedures for donor screening. Additionally, the firm's HCT/P records did not properly document the establishment responsible for donor eligibility determinations.

## Related Documents

- [483 - 2019-01-23](https://www.keypedia.com/records/483/new-york-cryo/236b776f-4af6-47a1-84a4-06a05cb781b9)
- [483 - 2024-03-21](https://www.keypedia.com/records/483/new-york-cryo/d7f52016-4169-4562-9b05-b25b6f623f36)
- [EIR - 2022-04-25](https://www.keypedia.com/records/eir/new-york-cryo/0cd735e8-adb7-4972-8828-c10cdc6a8678)

## Related Officers

- [Investigator](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/new-york-cryo/7fb7224b-266e-4404-8c5b-8999319c5a95

Office: https://www.keypedia.com/offices/division-of-human-and-animal-food-operations-east-i/a807f00e-d780-40b8-b233-1eb92ece8961